These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4625838)

  • 1. Ionic requirements for melanophore-stimulating hormone (MSH) release.
    Bower A; Hadley ME
    Gen Comp Endocrinol; 1972 Aug; 19(1):147-58. PubMed ID: 4625838
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of melanophore stimulating hormone (MSH) release.
    Hadley ME; Bower A; Hruby VJ
    Yale J Biol Med; 1973 Dec; 46(5):602-16. PubMed ID: 4544339
    [No Abstract]   [Full Text] [Related]  

  • 3. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic requirements for melanophore-stimulating hormone (MSH) secretion.
    Hadley ME; Bower SA
    Gen Comp Endocrinol; 1976 Feb; 28(2):118-30. PubMed ID: 1083822
    [No Abstract]   [Full Text] [Related]  

  • 5. Biogenic amines and control of melanophore stimulating hormone release.
    Bower A; Hadley ME; Hruby VJ
    Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1975; 17(4):296-308. PubMed ID: 1079927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic administration of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity.
    Peaslee MH; Goldman M; Milburn SE
    Comp Gen Pharmacol; 1972 Jun; 3(10):191-4. PubMed ID: 4542435
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.
    Huntington T; Hadley ME
    Endocrinology; 1974 Aug; 95(2):472-9. PubMed ID: 4546804
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the toxicity of ouabain in vivo and in vitro in the frog, Rana pipiens, and the toad, Bufo marinus.
    Liu AY; Bentley PJ
    Comp Gen Pharmacol; 1971 Dec; 2(8):476-8. PubMed ID: 4269642
    [No Abstract]   [Full Text] [Related]  

  • 10. Secretion of melanophore-stimulating hormone (MSH) in long-term cultures of pituitary neurointermediate lobes.
    Semoff S; Fuller BB; Hadley ME
    Cell Tissue Res; 1978 Nov; 194(1):55-69. PubMed ID: 309795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive method for the bioassay of melanocyte stimulating hormone in human saliva.
    Innes DL; Ritman L; Tansy MF
    J Dent Res; 1974; 53(4):814-20. PubMed ID: 4546332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of background adaptation, length of exposure time and hypophysectomy on the quantity of melanophore stimulating substances in the hypothalamo hypophyseal complex of Rana pipiens.
    Preslock JP; Bercu BB; Brinkley HJ
    Gen Comp Endocrinol; 1972 Oct; 19(2):313-9. PubMed ID: 4539045
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular control of melanocyte stimulating hormone secretion.
    Hadley ME; Davis MD; Morgan CM
    Front Horm Res; 1977; 4():94-104. PubMed ID: 26618
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-introduction and evaluation of an accurate, high capacity bioassay for melanocyte-stimulating hormone using the skin of Anolis carolinensis in vitro.
    Tilders FJ; van Delft AM; Smelik PG
    J Endocrinol; 1975 Aug; 66(2):165-75. PubMed ID: 170354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for a potassium-like action of lithium ions on sodium efflux in frog skeletal muscle.
    Beaugé LA; Ortiz O
    J Physiol; 1972 Nov; 226(3):675-97. PubMed ID: 4637626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racemization effects on melanocyte-stimulating hormones and related peptides.
    Bool AM; Gray GH; Hadley ME; Heward CB; Hruby VJ; Sawyer TK; Yang YC
    J Endocrinol; 1981 Jan; 88(1):57-65. PubMed ID: 6970245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanophore stimulating hormone (MSH) release: inhibition by cytochalasin B and "stimulation" by dimethyl sulfoxide.
    Bower SA; Hadley ME
    Endocrinology; 1975 Feb; 96(2):431-9. PubMed ID: 1078655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms controlling melanophore stimulating hormone (MSH) release.
    Hadley ME; Hruby VJ; Bower A
    Gen Comp Endocrinol; 1975 May; 26(1):24-35. PubMed ID: 236974
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in the release of melanocyte-stimulating hormone in vitro by rat pituitary glands collected at various times during the oestrous cycle.
    Vivas A; Celis ME
    J Endocrinol; 1978 Jul; 78(1):1-6. PubMed ID: 567239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.